| Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children A Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, ... New England Journal of Medicine 378 (8), 731-739, 2018 | 2742 | 2018 |
| Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials DS Hong, SG DuBois, S Kummar, AF Farago, CM Albert, KS Rohrberg, ... The Lancet Oncology 21 (4), 531-540, 2020 | 919 | 2020 |
| Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study TW Laetsch, SG DuBois, L Mascarenhas, B Turpin, N Federman, ... The Lancet Oncology 19 (5), 705-714, 2018 | 554 | 2018 |
| PAX‐FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report SX Skapek, J Anderson, FG Barr, JA Bridge, JM Gastier‐Foster, ... Pediatric blood & cancer 60 (9), 1411-1417, 2013 | 278 | 2013 |
| Thyroid cancer in the pediatric population VA Paulson, ER Rudzinski, DS Hawkins Genes 10 (9), 723, 2019 | 229 | 2019 |
| Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors ER Rudzinski, CM Lockwood, BA Stohr, SO Vargas, R Sheridan, JO Black, ... The American journal of surgical pathology 42 (7), 927-935, 2018 | 204 | 2018 |
| Testing algorithm for identification of patients with TRK fusion cancer F Penault-Llorca, ER Rudzinski, AR Sepulveda Journal of clinical pathology 72 (7), 460-467, 2019 | 189 | 2019 |
| The World Health Organization classification of skeletal muscle tumors in pediatric rhabdomyosarcoma: a report from the Children's Oncology Group ER Rudzinski, JR Anderson, DS Hawkins, SX Skapek, DM Parham, ... Archives of pathology & laboratory medicine 139 (10), 1281-1287, 2015 | 184 | 2015 |
| Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: a report from the … DS Hawkins, YY Chi, JR Anderson, J Tian, CAS Arndt, L Bomgaars, ... Journal of Clinical Oncology 36 (27), 2770-2777, 2018 | 167 | 2018 |
| Genomic classification and clinical outcome in rhabdomyosarcoma: a report from an international consortium JF Shern, J Selfe, E Izquierdo, R Patidar, HC Chou, YK Song, ME Yohe, ... Journal of Clinical Oncology 39 (26), 2859-2871, 2021 | 161 | 2021 |
| Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the Children's … E Hibbitts, YY Chi, DS Hawkins, FG Barr, JA Bradley, R Dasgupta, ... Cancer medicine 8 (14), 6437-6448, 2019 | 133 | 2019 |
| Expanding the spectrum of pediatric NTRK-rearranged mesenchymal tumors JL Davis, CM Lockwood, B Stohr, C Boecking, A Al-Ibraheemi, SG DuBois, ... The American journal of surgical pathology 43 (4), 435-445, 2019 | 126 | 2019 |
| Infantile NTRK-associated Mesenchymal Tumors JL Davis, CM Lockwood, CM Albert, K Tsuchiya, DS Hawkins, ... Pediatric and Developmental Pathology 21 (1), 68-78, 2018 | 118 | 2018 |
| Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: a report from the Children's Oncology Group ER Rudzinski, JR Anderson, YY Chi, JM Gastier‐Foster, C Astbury, ... Pediatric blood & cancer 64 (12), e26645, 2017 | 107 | 2017 |
| Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology … ER Rudzinski, LA Teot, JR Anderson, J Moore, JA Bridge, FG Barr, ... American journal of clinical pathology 140 (1), 82-90, 2013 | 95 | 2013 |
| What is new in the biology and treatment of pediatric rhabdomyosarcoma? DS Hawkins, AA Gupta, ER Rudzinski Current opinion in pediatrics 26 (1), 50-56, 2014 | 86 | 2014 |
| Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic transcription factors KL MacQuarrie, Z Yao, AP Fong, SJ Diede, ER Rudzinski, DS Hawkins, ... Molecular and cellular biology, 2013 | 82 | 2013 |
| NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including … JT Rabban, WP Devine, AR Sangoi, L Poder, E Alvarez, JL Davis, ... Histopathology 77 (1), 100-111, 2020 | 80 | 2020 |
| DUX4 immunohistochemistry is a highly sensitive and specific marker for CIC-DUX4 fusion-positive round cell tumor B Siegele, J Roberts, JO Black, E Rudzinski, SO Vargas, C Galambos The American journal of surgical pathology 41 (3), 423-429, 2017 | 80 | 2017 |
| Histology, fusion status, and outcome in alveolar rhabdomyosarcoma with low‐risk clinical features: a report from the Children's Oncology Group MA Arnold, JR Anderson, JM Gastier‐Foster, FG Barr, SX Skapek, ... Pediatric blood & cancer 63 (4), 634-639, 2016 | 74 | 2016 |
Douglas S. HawkinsSeattle Children's HospitalVerified email at seattlechildrens.org